|
.: Leading On-Line Research Tool for Biomedical Intelligence :.
|
|
|
|
Our Deals & Alliances database, which includes many of the Life Science transactions over the last twenty years,
is updated on a daily basis. We rely on annual reports, regulatory filings, press releases, articles, websites and company contacts
to source this information. Deal economics are subject to timing and we combine the most up-to-date information with the ability
to gain a historical perspective by searching the database. We have summarized key categories of deal types
for your convenience and will continue to update them as our database expands.
Key Lists
 Top 2011 Deals and Alliances by Value
| Source |
Partner |
Deal Value
in $millions |
Date |
| -- | Eli Lilly and Company
Boehringer Ingelheim GmbH
Boehringer Ingelheim Pharmaceuticals, Inc.
| 1,844.5 | January 11, 2011 |
Otsuka Pharmaceutical Co., Ltd.
| H. Lundbeck A/S
| 1,800.0 | November 11, 2011 |
Alios BioPharma, Inc.
| Vertex Pharmaceuticals Incorporated
| 1,525.0 | June 13, 2011 |
AVEO Pharmaceuticals, Inc. (formerly GenPath Pharmaceuticals, Inc.)
| Astellas Pharma, Inc.
| 1,480.0 | February 16, 2011 |
miRagen Therapeutics, Inc.
| Les Laboratoires Servier
| 1,000.0 | October 18, 2011 |
Micromet, Inc.
| Amgen, Inc.
| 991.4 | July 11, 2011 |
Pharmacyclics, Inc.
| Janssen Biotech, Inc. (formerly Centocor Ortho Biotech, Inc.)
| 975.0 | December 08, 2011 |
XOMA, Ltd.
| Les Laboratoires Servier
| 885.0 | January 04, 2011 |
Evotec AG
| Roche Holding, Ltd.
| 830.0 | September 05, 2011 |
Intra-Cellular Therapies, Inc.
| Takeda Pharmaceutical Company Limited
| 750.0 | March 02, 2011 |
Top M&A 2011 Stats
| Acquirer |
Target |
M&A Date |
M&A Price in $millions |
| Express Scripts, Inc. (ESRX) |
Medco Health Solutions, Inc. (formerly Merck Medco Managed Care LLC) (MHS) |
July 20, 2011 |
29,100 |
| Johnson & Johnson (JNJ) |
Synthes, Inc. (SYST) |
April 27, 2011 |
21,300 |
| Takeda Pharmaceutical Company Limited (4502) |
Nycomed International Management GmbH |
September 30, 2011 |
13,682 |
| E. I. du Pont de Nemours and Company (DD) |
Danisco A/S (DCO) |
January 09, 2011 |
7,137 |
| HCP, Inc. (formerly Health Care Property Investors, Inc.) (HCP) |
HCR ManorCare, Inc. - Real Estate Assets - US |
April 08, 2011 |
6,100 |
| Thermo Fisher Scientific, Inc. (Formerly Thermo Electron Corporation) (TMO) |
Phadia AB |
August 23, 2011 |
3,520 |
| Endo Pharmaceuticals Holdings, Inc. (ENDP) |
American Medical Systems Holdings, Inc. (AMMD) |
June 20, 2011 |
2,900 |
| Terumo Corporation (4543) |
CaridianBCT, Inc. |
April 14, 2011 |
2,628 |
| Cargill, Incorporated |
Provimi SA (VIM) |
November 22, 2011 |
2,138 |
| Fresenius Medical Care AG & Co. KGaA (FME) |
Liberty Dialysis Holdings, Inc. |
August 01, 2011 |
1,700 |
|
|
|
| |
 |
The information contained herein is based on sources believed to be reliable but is
neither all-inclusive nor guaranteed by Life Science Analytics ("LSA"). Opinions, if any,
reflect the judgment of LSA at this time and are subject to change. LSA does not undertake
to advise you of changes in their opinion or information. Most of the companies LSA follows
are emerging growth companies whose securities typically involve a higher degree of risk and
more volatility than the securities of more established companies. The securities discussed
in the reports included in LSA's Database may be unsuitable for investors depending on their
specific investment objectives, financial situation and needs. No report included in the LSA
Database is a recommendation that any particular investor should purchase or sell any
particular security in any amount or at all, and is not a solicitation of any offer to
purchase or sell from or to any particular investor. For additional information that may be
available on the securities mentioned, please contact Life Science Analytics.
|
|
|
 |
 |
|
